These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3996317)

  • 1. Cysteamine causes reduction of prolactin monomers followed by aggregation in the rat pituitary gland.
    Scammell JG; Burrage TG; Eisenfeld AJ; Dannies PS
    Endocrinology; 1985 Jun; 116(6):2347-54. PubMed ID: 3996317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro conditions modify immunoassayability of bovine pituitary prolactin and growth hormone: insights into their secretory granule storage forms.
    Lorenson MY
    Endocrinology; 1985 Apr; 116(4):1399-407. PubMed ID: 3918853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
    Scammell JG; Dannies PS
    Endocrinology; 1984 Mar; 114(3):712-6. PubMed ID: 6697959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cysteamine, zinc, and thiols modify detectability of rat pituitary prolactin: a comparison with effects on bovine prolactin suggests differences in hormone storage.
    Jacobs LS; Lorenson MY
    Metabolism; 1986 Mar; 35(3):209-15. PubMed ID: 3081777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detectability of pituitary PRL and GH by immunoassay is increased by thiols and suppressed by divalent cations.
    Lorenson MY; Robson DL; Jacobs LS
    Endocrinology; 1983 May; 112(5):1880-2. PubMed ID: 6403341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteamine inhibition of bovine pituitary secretory granule prolactin immunoassayability and release.
    Lorenson MY
    Endocrinology; 1984 Aug; 115(2):728-35. PubMed ID: 6745176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine depletes prolactin (PRL) but does not alter the structure of PRL-containing granules in the anterior pituitary.
    Weinstein LA; Landis DM; Sagar SM; Millard WJ; Martin JB
    Endocrinology; 1984 Oct; 115(4):1543-50. PubMed ID: 6479101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of bovine pituitary prolactin by cysteamine involves a thiol:disulfide mechanism.
    Lorenson MY; Jacobs LS
    Endocrinology; 1984 Oct; 115(4):1492-5. PubMed ID: 6479100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in molecular variants during in vitro transformation and release of prolactin by the pituitary gland of the lactating rat.
    Mena F; Hummelt G; Aguayo D; Clapp C; Martínez de la Escalera G; Morales MT
    Endocrinology; 1992 Jun; 130(6):3365-77. PubMed ID: 1597148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mechanism of action of cysteamine in depleting prolactin immunoreactivity.
    Sagar SM; Millard WJ; Martin JB; Murchison SC
    Endocrinology; 1985 Aug; 117(2):591-600. PubMed ID: 3926458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolactin (PRL) processing by kallikrein: production of the 21-23.5K PRL-like molecules and inferences about PRL storage in mature secretory granules.
    Ho TW; Balden E; Chao J; Walker AM
    Endocrinology; 1991 Jul; 129(1):184-92. PubMed ID: 2055182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 22K variant of rat prolactin: evidence for identity to prolactin-(1-173), storage in secretory granules, and regulated release.
    Anthony PK; Stoltz RA; Pucci ML; Powers CA
    Endocrinology; 1993 Feb; 132(2):806-14. PubMed ID: 8425495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cysteamine on pituitary, MTTW15 tumor, and serum prolactin levels measured by rat lymphoma cell bioassay and radioimmunoassay.
    Parsons JA; Peterson EK; Hartfel MA
    Endocrinology; 1984 May; 114(5):1812-7. PubMed ID: 6714167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteamine inhibition of prolactin immunoassayability and secretion: studies with aminothiophenols and other analogs.
    Jacobs LS; Lorenson MY
    Endocrinology; 1984 Sep; 115(3):1210-7. PubMed ID: 6430683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of cysteamine induction of the 22K prolactin variant in the rat pituitary.
    Anthony PK; Powers CA
    Neuroendocrinology; 1993 Jan; 57(1):167-76. PubMed ID: 8479612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colocalization of galanin and prolactin within secretory granules of anterior pituitary cells in estrogen-treated Fischer 344 rats.
    Hyde JF; Engle MG; Maley BE
    Endocrinology; 1991 Jul; 129(1):270-6. PubMed ID: 1711463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential interaction of [35S]cysteamine with pituitary secretory granule storage forms of prolactin.
    Lorenson MY; Jacobs LS
    Neuroendocrinology; 1988 Apr; 47(4):358-64. PubMed ID: 3374761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of growth hormone and prolactin in secretory granules of the normal and neoplastic human adenohypophysis.
    Zurschmiede C; Landolt AM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(5):308-15. PubMed ID: 2889294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcellular localization of dopamine in the anterior pituitary gland of the rat: apparent association of dopamine with prolactin secretory granules.
    Nansel DD; Gudelsky GA; Porter JC
    Endocrinology; 1979 Nov; 105(5):1073-7. PubMed ID: 226346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of estradiol on prolactin and growth hormone messenger RNAs in cultured normal and neoplastic (MtT/W15 and GH3) rat pituitary cells.
    Song JY; Jin L; Lloyd RV
    Cancer Res; 1989 Mar; 49(5):1247-53. PubMed ID: 2917354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.